Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding AU:CURE?
Track your performance easily
AU:CURE Price & Analysis
CURE ETF Chart & Stats
Day’s Range― - ―
52-Week Range36.05 - 54.72
Previous Close53.7
VolumeN/A
Average Volume (3M)1.63K
AUM39.12M
NAV51.03
Expense Ratio0.45%
Holdings CountN/A
Beta0.87
Inception DateNov 08, 2018
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.07
10 Day Avg. Volume2,062
30 Day Avg. Volume1,632
Alpha0.00034
Global X S&P Biotech ETF (CURE) Fund Flow Chart
Global X S&P Biotech ETF (CURE) 1 year Net Flows: -5M
CURE ETF FAQ
What was AU:CURE’s price range in the past 12 months?
AU:CURE lowest ETF price was 36.05 and its highest was 54.72 in the past 12 months.
What is the AUM of AU:CURE?
As of Oct 28, 2024 The AUM of AU:CURE is 39.12M.
Is AU:CURE overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does AU:CURE pay dividends?
AU:CURE does not currently pay dividends.
How many shares outstanding does AU:CURE have?
Currently, no data Available
Which hedge fund is a major shareholder of AU:CURE?
Currently, no hedge funds are holding shares in AU:CURE
ETF Description
Global X S&P Biotech ETF
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.